STAAR Surgical director granted 3,091 RSUs, 5,572 options

Zhou Lilian Yansheng reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Zhou Lilian Yansheng reported acquisition or exercise transactions in this Form 4 filing.

STAAR Surgical director Lilian Yansheng Zhou received new equity awards as part of the company’s annual non-employee director compensation for the 2026-2027 term. On June 18, 2026, Zhou was granted options to purchase 5,572 shares of common stock at $29.12 per share, expiring June 17, 2036.

Zhou also received 3,091 restricted stock units tied to common stock. According to the grant terms, both the options and the restricted stock units vest in full on the earlier of June 18, 2027 or STAAR Surgical’s 2027 Annual Meeting of Shareholders.

Insider Trade Summary

Grant/Award: 8,663 shares

Grant/Award 2 txns

Insider Zhou Lilian Yansheng

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	3,091	$0.00	$0.00
Grant/Award	Common Stock Options	5,572	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 3,091 contracts (Direct); Common Stock Options — 5,572 contracts (Direct)

Footnotes (1)

1. F1. Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Key Figures

Options granted: 5,572 options Option exercise price: $29.12 per share Option expiration: June 17, 2036 +4 more

7 metrics

Options granted 5,572 options Common stock options granted on June 18, 2026

Option exercise price $29.12 per share Exercise price for 5,572 common stock options

Option expiration June 17, 2036 Expiration date of granted common stock options

Restricted stock units granted 3,091 RSUs RSUs linked to common stock granted June 18, 2026

Total options after grant 5,572 options Total options held following the June 18, 2026 grant

Total RSUs after grant 3,091 RSUs Total restricted stock units held following the grant

Derivative transactions 2 transactions Number of derivative-type grant transactions reported

Key Terms

Restricted Stock Units, annual non-employee director equity compensation program, vest in full

3 terms

Restricted Stock Units financial

"Reflects restricted stock units and options to purchase common stock granted to the Reporting Person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual non-employee director equity compensation program financial

"pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term"

vest in full financial

"These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders"

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhou Lilian Yansheng

(Last) (First) (Middle)

25510 COMMERCENTRE DRIVE

(Street)

LAKE FOREST CALIFORNIA 92630

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	$0	06/18/2026		A		3,091		(1)	(1)	Common Stock	3,091	$0	3,091	D
Common Stock Options(1)	$29.12	06/18/2026		A		5,572		06/18/2027	06/17/2036	Common Stock	5,572	$0	5,572	D

Explanation of Responses:

1. Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

Remarks:

This Form 4 reflects the equity awards granted to the Reporting Person on June 18, 2026 pursuant to Issuer's annual non-employee director equity compensation program for the 2026-2027 term.

	/s/ Kathleen Determann as attorney-in-fact for Lilian Y. Zhou	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)